Funding for this research was provided by:
Thailand Research Fund (RTA6080009)
Received: 11 September 2020
Accepted: 8 April 2021
First Online: 17 April 2021
: Ethics approvals were obtained from the institutional review boards, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. The informed written consent was obtained from participants prior to enrollment.
: Not applicable
: HN received speaker honoraria from Novo Nordisk, Takeda, MSD, Sanofi Aventis, Amgen, Eli lily, Boehringer Ingelheim Pharmaceuticals and Novartis. SR received speaker honoraria from Novo Nordisk, Sanofi Aventis and Medtronic; a research grant from Merck Sharp and Dohme; and non-financial support from ResMed, Thailand<b>.</b> SS, CA, SS, RJ, AH, SS, WT, NS, JS, OP and AP report no conflicts of interest.